Markets
ABUS

Arbutus Biopharma Corp. Q2 Earnings Summary

August 06, 2025 — 07:49 am EDT

Written by RTTNews.com for RTTNews->

(RTTNews) - Below are the earnings highlights for Arbutus Biopharma Corp. (ABUS):

Earnings: $2.523 million in Q2 vs. -$19.796 million in the same period last year. EPS: $0.01 in Q2 vs. -$0.11 in the same period last year. Revenue: $10.739 million in Q2 vs. $1.726 million in the same period last year.

ABUS was up by 3.81% at $3.540 in the pre-market trade on the Nasdaq.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

Markets
RTTNews
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.
More articles by this source->

Stocks mentioned

ABUS

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

  • •

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.